Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Repare Therapeutics Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $140.00M | $140.00M - $140.00M | -$115.78M | -$0.65 | 1 |
| Dec 2028 | $15.00M | $15.00M - $15.00M | -$12.41M | -$0.60 | 1 |
| Dec 2027 | $9.41M | $9.41M - $9.41M | -$7.78M | -$0.60 | 1 |
| Dec 2026 | $6.67M | $6.67M - $6.67M | -$5.51M | -$1.26 | 1 |
| Dec 2025 | $300.0K | $300.0K - $300.0K | -$248.1K | -$1.73 | 1 |
| Dec 2024 | $56.23M | $53.04M - $62.05M | -$46.50M | -$2.104 | 6 |
| Dec 2023 | $68.68M | $68.68M - $68.68M | -$56.80M | -$1.623 | 5 |
| Dec 2022 | $122.28M | $89.78M - $154.79M | -$101.13M | -$0.66 | 2 |
| Dec 2021 | $3.99M | $2.93M - $5.05M | -$3.30M | -$2.796 | 5 |
| Dec 2020 | $1.50M | $1.10M - $1.90M | -$1.24M | -$2.00 | 3 |